The initial results suggest that Exact’s test could be an alternative to others on the market, but the findings come from a ...

Biopsy Devices Market size is valued at $2.71 Billion by 2030, and is anticipated to grow at a CAGR of 4% during the forecast ...

Detecting clinically insignificant cancer in the MRI-targeted biopsy group versus the systematic biopsy group had a relative risk of 0.43 (95 percent confidence interval, 0.32 to 0.57) and was ...

Investors have poured billions of dollars into the "liquid biopsy" space for the early detection and tracking of cancer. Now ...

Aug. 14, 2024 — A new study has identified diet-derived molecules called metabolites as main drivers of young-onset colorectal cancer risk, especially those associated with red and processed meat.

While battling cancer, country singer Joshua Ray Walker decided to share an update with fans inside the hospital.

A positive update from Joshua Ray Walker. Late last year, Joshua shared with fans that he was diagnosed with colon cancer, ...

Exact Sciences has a multipronged approach to cancer testing. Current products are Cologuard, its flagship stool-based screening test for colorectal cancer, or CRC, and Oncotype DX, its tissue-based ...

On September 10, the country singer — who was diagnosed with colon cancer last year — posted a health update on Instagram, ...